Crossmark Global Holdings, Inc. Shockwave Medical, Inc. Transaction History

Crossmark Global Holdings, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$191.17 - $325.63 $115,657 - $197,006	-605 Reduced 9.79%	5,575 $1.82 Million
Q4 2023 Feb 13, 2024	SELL	$160.99 - $215.69 $36,544 - $48,961	-227 Reduced 3.54%	6,180 $1.18 Million
Q3 2023 Nov 08, 2023	BUY	$194.33 - $283.97 $25,262 - $36,916	130 Added 2.07%	6,407 $1.35 Million
Q2 2023 Jul 31, 2023	SELL	$223.05 - $302.68 $8,029 - $10,896	-36 Reduced 0.57%	6,277 $1.65 Million
Q1 2023 May 12, 2023	BUY	$175.41 - $217.92 $13,506 - $16,779	77 Added 1.23%	6,313 $1.37 Million
Q4 2022 Jan 19, 2023	BUY	$204.38 - $296.82 $188,847 - $274,261	924 Added 17.39%	6,236 $1.28 Million
Q3 2022 Nov 01, 2022	SELL	$195.21 - $310.53 $181,935 - $289,413	-932 Reduced 14.93%	5,312 $1.48 Million
Q2 2022 Jul 29, 2022	BUY	$115.91 - $214.48 $339,848 - $628,855	2,932 Added 88.53%	6,244 $1.19 Million
Q1 2022 May 11, 2022	BUY	$127.96 - $207.36 $182,087 - $295,073	1,423 Added 75.33%	3,312 $687,000
Q4 2021 Jan 10, 2022	BUY	$165.13 - $241.83 $311,930 - $456,816	1,889 New	1,889 $337,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.